Since 1970, several CPVT mutations in ion channel genes or calcium-binding proteins have been identified: ryanodine receptor 2 (RYR2), calsequestrin 2 (CASQ2), and triadin (TRDN)4. This evidence concerns the gene CASQ2 and catecholaminergic polymorphic ventricular tachycardia.